Teladoc Health (TDOC) Cash from Financing Activities (2014 - 2026)

Teladoc Health has reported Cash from Financing Activities for 13 years, with the latest figure at $875000.0 in Q2 2026.

• Quarterly Cash from Financing Activities rose 100.16% year-over-year to $875000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$4.1 million (up 99.26% YoY) and the FY2025 annual result came in at -$551.7 million, down 6736.81% from the prior year.
• Cash from Financing Activities improved to $875000.0 in Q2 2026 per TDOC's latest filing, from -$2.4 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $5.1 million in Q3 2023 and troughed at -$549.9 million in Q2 2025.
• A 5-year average of -$29.3 million and a median of $989500.0 in 2025 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities jumped 699.37% in 2023, then slumped 14552.9% in 2025.
• Over 5 years, Cash from Financing Activities stood at $4.4 million in 2022, then plunged by 140.52% to -$1.8 million in 2023, then surged by 215.94% to $2.1 million in 2024, then slumped by 46.36% to $1.1 million in 2025, then fell by 20.74% to $875000.0 in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $875000.0, -$2.4 million, and $1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.